PositiveID Corp. (OTCQB: PSID) develops molecular diagnostics systems for bio-threat detection and rapid medical testing. The company’s M-BAND system, developed under contract with the U.S. Department of Homeland Security Science & Technology, continuously and autonomously analyzes air samples for the detection of biological threats in the form of bacteria, viruses, and toxins. PositiveID’s Firefly Dx is a handheld system designed to deliver molecular diagnostic results for healthcare and molecular diagnostics markets for more rapid and accurate point-of-need detection and diagnostics. For more information, visit the company’s website at www.positiveidcorp.com